Tectonic Therapeutic (TECX) Shares Outstanding (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Shares Outstanding (Entity) of $18.8 million for Q1 2026, up 0.85% year-over-year from $18.7 million in Q1 2025, and little changed quarter-over-quarter from $18.7 million in Q4 2025.
Tectonic Therapeutic (TECX) Shares Outstanding (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Shares Outstanding (Entity) for 10 consecutive years, with $18.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 0.85% year-over-year to $18.8 million; the TTM figure through Mar 2026 stood at $18.8 million (up 0.85% YoY), while the FY2025 annual figure was $18.7 million, up 120.71% from the prior year.
- Shares Outstanding (Entity) steadied at $18.8 million in Q1 2026 per TECX's latest filing, from $18.7 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $18.8 million in Q1 2026 and bottomed at $3641.0 in Q2 2022.
- Historically, Shares Outstanding (Entity) has averaged $8.1 million across 5 years, with a median of $3.7 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) sank 99.9% — and 2023, when it jumped 101985.54%.
- Tectonic Therapeutic's Shares Outstanding (Entity) stood at $3645.0 in 2022, then surged by 101985.54% to $3.7 million in 2023, then surged by 128.17% to $8.5 million in 2024, then soared by 120.71% to $18.7 million in 2025, then grew by 0.49% to $18.8 million in 2026.
- Business Quant data shows TECX's Shares Outstanding (Entity) at $18.8 million in Q1 2026, $18.7 million in Q4 2025, and $18.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 18.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.96 Mn |
| Mar 31, 2026 | 18.77 Mn |
| Dec 31, 2025 | 18.32 Mn |
| Sep 30, 2025 | 18.71 Mn |
| Jun 30, 2025 | 18.68 Mn |
| Mar 31, 2025 | 17.16 Mn |
| Dec 31, 2024 | 8.49 Mn |
| Sep 30, 2024 | 14.73 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 3,670.00 |
| Dec 31, 2022 | 3,645.00 |
| Sep 30, 2022 | 3,648.00 |
| Jun 30, 2022 | 3,641.00 |
| Mar 31, 2022 | 3.64 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 3.64 Mn |